{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:59:42Z","timestamp":1760731182367,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jfo.2018.06.007","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T23:23:06Z","timestamp":1553728986000},"page":"464-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact du traitement antiglaucomateux et de la pathologie de la surface oculaire sur la qualit\u00e9 de vie des patients glaucomateux dans la r\u00e9gion de Sousse (Tunisie)"],"prefix":"10.1016","volume":"42","author":[{"given":"K.","family":"Leila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gatfaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mahjoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yakoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Krifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ghorbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mahjoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2018.06.007_bib0205","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Progress in retinal and eye research preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.jfo.2018.06.007_bib0210","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jfo.2016.11.010","article-title":"\u00c9tude pr\u00e9liminaire de la qualit\u00e9 de vie des patients glaucomateux dans la r\u00e9gion de Sousse (Tunisie): associations sociod\u00e9mographiques et cliniques","volume":"40","author":"Knani","year":"2017","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0215","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/696328","article-title":"How ocular surface disease impacts the glaucoma treatment outcome","volume":"2013","author":"Ka\u0161telan","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jfo.2018.06.007_bib0220","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/112067210901900409","article-title":"Dry eye syndrome-related quality of life in glaucoma patients","volume":"19","author":"Rossi","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0225","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0161-6420(98)93043-3","article-title":"Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study","volume":"105","author":"Sherwood","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2018.06.007_bib0230","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/jop.2004.20.461","article-title":"Patient and ophthalmologist compliance and dosing in glaucoma treatment","volume":"20","author":"Stewart","year":"2004","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2018.06.007_bib0235","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/271425","article-title":"Vision health-related quality of life in chinese glaucoma patients","volume":"2015","author":"Zuo","year":"2015","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0240","first-page":"274","article-title":"\u201cThe association between clinical parameters and glaucoma- specific quality of life in Chinese primary open-angle glaucoma patients\u201d","volume":"20","author":"Lee","year":"2014","journal-title":"HongKong Med J"},{"key":"10.1016\/j.jfo.2018.06.007_bib0245","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archopht.1997.01100160617016","article-title":"Visual function and quality of life among patients with glaucoma","volume":"115","author":"Parrish","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0250","doi-asserted-by":"crossref","first-page":"75Y81","DOI":"10.1016\/S1543-5946(03)90003-1","article-title":"Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organization","volume":"1","author":"Balkrishnan","year":"2003","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jfo.2018.06.007_bib0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/IJG.0b013e31819d5cf7","article-title":"Vision-specific quality of life in Greek glaucoma patients","volume":"19","author":"Labiris","year":"2010","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jfo.2018.06.007_bib0260","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/bjo.2005.068858","article-title":"Utility values among glaucoma patients: an impact on the quality of life","volume":"10","author":"Gupta","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0265","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0161-6420(98)91135-6","article-title":"Functional status and wellbeing in patients with glaucoma as measured by the medical outcomes study short form-36\u00a0questionnaire","volume":"105","author":"Wilson","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2018.06.007_bib0270","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0181-5512(06)73905-5","article-title":"Pr\u00e9valence et description du traitement par hypotonisants pour glaucome et hypertonie oculaire en France","volume":"29","author":"Delcourt","year":"2006","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0275","first-page":"4","volume":"8","author":"Baudouin","year":"2013","journal-title":"Glaucoma and ocular surface disease: who, why and how to treat?\u201d View on Glaucoma"},{"key":"10.1016\/j.jfo.2018.06.007_bib0280","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0420.1998.tb00887.x","article-title":"Glaucoma and quality of the life","volume":"227","author":"Perfetti","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jfo.2018.06.007_bib0285","first-page":"1","article-title":"Ocular surface disease and quality of life in patients with glaucoma","volume":"153","author":"Skalicky","year":"2012","journal-title":"AJOPHT"},{"key":"10.1016\/j.jfo.2018.06.007_bib0290","doi-asserted-by":"crossref","first-page":"129e137","DOI":"10.1038\/sj.eye.6701441","article-title":"Alphagan allergy may increase the propensity for multiple eye-drop allergy","volume":"19","author":"Osborne","year":"2005","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jfo.2018.06.007_bib0295","doi-asserted-by":"crossref","first-page":"4872e4880","DOI":"10.1167\/iovs.07-0984","article-title":"Effects of oxidative stress intrabecularmesh work cells are reduced by prostaglandin analogues","volume":"49","author":"Yu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2018.06.007_bib0300","first-page":"4594e4599","article-title":"In vitro comparison of cytoprotective andantioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelialcells","volume":"46","author":"Guenoun","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2018.06.007_bib0305","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bjo.79.4.339","article-title":"\u201cEffect of timolol with and without preservative on the basal tear turnover in glaucoma\u201d","volume":"79","author":"Kuppens","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0310","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"\u201cPrevalence of ocular surface disease in glaucoma patients\u201d","volume":"17","author":"Leung","year":"2008","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jfo.2018.06.007_bib0315","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","article-title":"Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressurelowering medications","volume":"29","author":"Fechtner","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2018.06.007_bib0320","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9394(14)71688-5","article-title":"Prevalence of dry eye among the elderly","volume":"124","author":"Schein","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0325","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ico.0000220776.93852.d9","article-title":"Incidence and prevalence of glaucoma in severe ocular surface disease","volume":"25","author":"Tsai","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2018.06.007_bib0330","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/IJG.0b013e318163bdd1","article-title":"Depression and quality of life in patients with glaucoma: a crosssectional analysis using the geriatric depression scale-15, assessment of function related to vision, and the glaucoma quality of life-15","volume":"17","author":"Skalicky","year":"2008","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jfo.2018.06.007_bib0335","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00061198-200204000-00012","article-title":"Glaucoma patients\u2019 assessment of their visual function and quality of life","volume":"11","author":"Jampel","year":"2002","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jfo.2018.06.007_bib0340","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0161-6420(00)00624-2","article-title":"Quality of life in newly diagnosed glaucoma patients: the collaborative initial glaucoma treatment study","volume":"108","author":"Janz","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2018.06.007_bib0345","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archopht.1997.01100150779014","article-title":"Influence of glaucomatous visual field loss on health-related quality of life","volume":"115","author":"Gutierrez","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0350","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00061198-200304000-00009","article-title":"Quality of life in glaucoma and its relationship with visual function","volume":"12","author":"Nelson","year":"2003","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jfo.2018.06.007_bib0355","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/IJG.0b013e3181752c83","article-title":"Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire","volume":"18","author":"Goldberg","year":"2009","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jfo.2018.06.007_bib0360","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","article-title":"Utility assessment among patients with dry eye disease","volume":"110","author":"Schiffman","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2018.06.007_bib0365","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/978-1-4615-0717-8_167","article-title":"Economic and quality of life impact of dry eye symptoms in women with Sjogren's syndrome","volume":"506 (PtB)","author":"Sullivan","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0370","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/00003226-200208000-00009","article-title":"Performance and repeatability of the NEI-VFQ-25\u00a0in patients with dry eye","volume":"21","author":"Nichols","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2018.06.007_bib0375","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","article-title":"Impact of dry eye syndrome on vision-related quality of life","volume":"143","author":"Miljanovic","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0380","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7525-1-75","article-title":"Vision related quality of life and topical glaucoma treatment side effects","volume":"1","author":"Nordmann","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jfo.2018.06.007_bib0385","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.ophtha.2013.03.045","article-title":"Evaluation of ocular surface disease in patients with glaucoma","volume":"120","author":"Mathews","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2018.06.007_bib0390","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1442-9071.2012.02781.x","article-title":"Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication","volume":"40","author":"Ghosh","year":"2012","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jfo.2018.06.007_bib0395","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2018.06.007_bib0400","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ophtha.2007.03.012","article-title":"Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15\u00a0% or brinzolamide 1\u00a0% in combination with travoprost 0.004%","volume":"114","author":"Feldman","year":"2007","journal-title":"Ophthalmology"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551218305308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551218305308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:09:04Z","timestamp":1759259344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551218305308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0181551218305308"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2018.06.007","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact du traitement antiglaucomateux et de la pathologie de la surface oculaire sur la qualit\u00e9 de vie des patients glaucomateux dans la r\u00e9gion de Sousse (Tunisie)","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2018.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}